Immuno-therapy may prolong lives of men with advanced prostate cancer

MEDPAGE TODAY: A cellular immuno-therapy appears to prolong survival among men with metastatic, castration-resistant prostate cancer, researchers report. READ MORE>

Read Full Post »

Prostate cancer drug market will double in value in next decade

PR NEWSWIRE: The launch and uptake of nine emerging therapies will drive the prostate cancer drug market to more than double, from nearly $4 billion in 2009 to $8.4 billion in 2019 in the US, France, Germany, Italy, Spain, the UK and Japan. READ MORE>

Read Full Post »

Drug/vaccine combo experiment being tried on advanced prostate cancer

URO TODAY: An experiment that combines a standard advanced prostate cancer drug treatment with a vaccine to assist the immune system has just begun in the US. READ MORE> Looking to harness the body’s own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators [...]

Read Full Post »

Problems delivering genes to target cells must be solved for immunotherapy to work

URO TODAY: Technological difficulties must be addressed before an efficient and safe gene medicine using immunotherapy is achieved (primarily by developing a means of delivering genes to the target cells or tissue safely and efficiently). READ MORE>

Read Full Post »

Prostate cancer cells in mice turn anti-tumour T-cells into cells that suppress immune system

URO TODAY: Researchers have discovered that prostate tumours in mice can cause immune cells known as CD8+ T cells to change to cells that suppress immune responses.

Read Full Post »

Widespread testing of new therapies for prostate cancer

URO TODAY: In the last several years, great strides have been made in our understanding of the biological and molecular mechanisms driving prostate cancer growth and progression, and this has resulted in widespread clinical testing of numerous new targeted therapies.

Read Full Post »

Leading Kiwi scientist will test his own prostate cancer treatment discovery on himself

AUGUST 2: PROSTABLOG NZ: A leading NZ scientist has discovered a novel compound he believes will suppress the prostate cancer that is killing him.

Read Full Post »

Provenge immunotherapy treatment for advanced prostate cancer emerges well from latest trial, with mild side effects

JULY 27: PUB MED: A trial involving men with hormone-refractory (advanced) prostate cancer who were  treated with Provenge (a cellular immunotherapy product called Sipuleucel-T) had a “survival benefit” and only modest side effects, say the Washington researchers. READ MORE> The integrated results…demonstrate a survival benefit for patients treated with sipuleucel-T compared with those treated with [...]

Read Full Post »

Radio-immunotherapy promising as advanced prostate cancer treatment, warrants more research

JULY 24: URO TODAY: Metastatic prostate cancer is an attractive target for radio-immunotherapy (RIT), as no effective therapies are available.

Read Full Post »

PROSTATE FUTURE: New drug will be ready for baby boomers

JUNE 11: SEEKING ALPHA.COM: A groundbreaking new treatment for prostate cancer, Provenge, will likely receive US Food and Drug Administration approval and become widely available just as the first Baby Boomers reach 65 in 2010.

Read Full Post »